Monsanto strikes back at finding that Roundup is probably carcinogenic

• Monsanto (NYSE:MON-OLD) says it is “outraged” by the World Health Organization’s assessment that its Roundup weedkiller probably causes cancer.
• In a response to Friday’s WHO assessment of glyphosate, the active ingredient in Roundup, MON Chief Technology Officer Robb Fraley said WHO’s International Agency for Research on Cancer reached its conclusions by “cherry picking” data, and the company is seeking a meeting with senior WHO officials.
• “IARC’s process is not transparent, its decision is irresponsible, and it has the potential to cause confusion about such an important issue as safety,” Fraley said.
• MON fell 1.9% in today's trade on investor concerns about IARC’s view, but the key focus will rest on any actions taken by the U.S. EPA, which regulates the U.S. pesticides market and concluded in a 2012 study that glyphosate meets safety standards for human health when used in keeping with its label.